European Journal of Molecular & Clinical Medicine

Abstract

The LMA™ airway is an innovative supraglottic airway management device. Since its commercial introduction in 1988, the LMA™ airway has been used in over 200 million patients for routine and emergency procedures. The LMA Pro-Seal™ is an advanced form of airway that may be used for the same indications as the LMA Classic™. The Institutional Ethical committee approval was obtained before commencement of the study. Written informed consent was obtained from all the patients. A total of sixty adult patients between 18 and 50 years of ASA Physical status 1 & 2 of either sex was randomly selected from the routine list of surgical procedures under general anaesthesia were enrolled in the study. Among the groups, there was no significant difference between the preinduction, one, three and five minutes post insertion heart rate. When compared between the groups, there was no significant difference in the pre induction, one, three and five minutes post insertion mean blood pressure.